Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis [Retraction]

Feng M, Luo F, Wu H, et al. Drug Des Devel Ther. 2023;17:3169—3192. https://doi.org/10.2147/DDDT.S420135 We, the Editor and Publisher of Drug Design, Development and Therapy, have retracted the published article. After publication, image integrity concerns were raised regarding duplicated elements within Figures 4h (LP vs. YSHXD-H) and 5b (NLRP3-YSHXD-L vs. IL-1beta-UUO). When approached for an explanation, the authors did respond to our queries (stating the duplications were due to errors in image assembly) but were unable to provide a satisfactory explanation to address our concerns. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed about this retraction and they have agreed to retract the article. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-12-12
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis [Retraction]

Dove Medical Press (Taylor and Francis Group)
Inflammasome and immune disorders
article

Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis [Retraction]

article en

Abstract

Feng M, Luo F, Wu H, et al. Drug Des Devel Ther. 2023;17:3169—3192. https://doi.org/10.2147/DDDT.S420135 We, the Editor and Publisher of Drug Design, Development and Therapy, have retracted the published article. After publication, image integrity concerns were raised regarding duplicated elements within Figures 4h (LP vs. YSHXD-H) and 5b (NLRP3-YSHXD-L vs. IL-1beta-UUO). When approached for an explanation, the authors did respond to our queries (stating the duplications were due to errors in image assembly) but were unable to provide a satisfactory explanation to address our concerns. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed about this retraction and they have agreed to retract the article. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Dove Medical Press (Taylor and Francis Group)
Peace, Justice and strong institutions
Openalex Percentile: Top 37%
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.